Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection

J Virol. 2004 Sep;78(18):10096-103. doi: 10.1128/JVI.78.18.10096-10103.2004.

Abstract

Several primate models indicate that cytotoxic T lymphocyte-inducing vaccines may be unable to prevent human immunodeficiency virus infection but may have a long-term benefit in controlling viral replication and delaying disease progression. Here we show that analysis of the kinetics of antigen-specific CD8+ T-cell expansion suggests a delay in activation following infection that allows unimpeded early viral replication. Viral kinetics do not differ between controls and vaccinees during this delay phase. An increase in virus-specific CD8+ T-cell numbers around day 10 postinfection coincides with a slowing in viral replication in vaccinees and reduces peak viral loads by around 1 log. However, this response is too little too late to prevent establishment of persistent infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS Vaccines / pharmacology
  • Animals
  • CD8-Positive T-Lymphocytes / immunology*
  • Gene Products, gag / immunology
  • HIV Infections / immunology*
  • HIV Infections / virology*
  • HIV-1 / immunology*
  • HIV-1 / physiology
  • Humans
  • Immunodominant Epitopes
  • Kinetics
  • Macaca mulatta
  • SAIDS Vaccines / pharmacology
  • Simian Acquired Immunodeficiency Syndrome / immunology
  • Simian Acquired Immunodeficiency Syndrome / virology
  • Simian Immunodeficiency Virus / immunology
  • Simian Immunodeficiency Virus / physiology
  • Time Factors
  • Virus Replication

Substances

  • AIDS Vaccines
  • Gene Products, gag
  • Immunodominant Epitopes
  • SAIDS Vaccines